Beactica Therapeutics is a specialist drug discovery and development company, committed to the fight against cancer. Beactica is advancing a proprietary pipeline of first-in-class therapeutics by applying its molecular interaction-based drug discovery engine synergistically across multiple small molecule modalities – including allosteric modulators, protein–protein interaction inhibitors and targeted protein degraders (PROTACs).
Company Details
- Employees
- 16
- Founded
- -
- Address
- Virdings Allé 2, Uppsala,se-754 50,sweden
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- beactica.com
- Keywords
- Surface Plasmon Resonance (SPR), Fragment-Based Drug Discovery, Interaction Analysis, Kinetics, Mechanism of action, Oncology, PROTACs, Allosteric Modulators, Therapeutics, Drug Discovery.
- HQ
- Uppsala
Beactica Therapeutics Questions
Beactica Therapeutics's website is beactica.com
Beactica Therapeutics's LinkedIn profile is https://se.linkedin.com/company/beactica
Beactica Therapeutics has
16 employees.
View email and phone details for 16
employees at Beactica Therapeutics.
Beactica Therapeutics's industry is
Pharmaceutical Manufacturing
Beactica Therapeutics's top competitors are
Strike Pharma Ab,
Novavax,
Ilya Pharma,
Emplicure,
Akiram Therapeutics,
Elicera Therapeutics Ab,
Farmpharma,
Cytiva,
Double Bond Pharmaceutical International Ab,
Gradientech.
Beactica Therapeutics's categories are Pharmaceutical Manufacturing
Beactica Therapeutics's founding year is 2006
